N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation) - Hijazi, Z; Wallentin, L; Siegbahn, A (J Am Coll Cardiol, 2013)
et al.